More than 80% of patients with tuberculosis do not have persistent cough, study shows

More than 80% of patients with tuberculosis, the world’s most deadly infection, do not have a persistent cough, despite this being seen as a key symptom of the disease.

Study links long-term health risks with burn pit exposure in military veterans

Study links extended deployments at military bases with open burn pits to a higher risk of developing respiratory and cardiovascular diseases, including COPD, asthma, and

April 29, 2024

Gilead partners with PANTHERx for LIVDELZI distribution

LIVDELZI is intended to be used in combination with ursodeoxycholic acid for PBC patients. Credit: Gilead Sciences, Inc./ Business Wire. Gilead Sciences has formed a

August 19, 2024

Risk of aspiration during surgery added to GLP-1 drug labels

This story first appeared in The Readout newsletter. Sign up for The Readout and receive STAT’s award-winning biotech news delivered straight to your inbox. Good morning! Today, we talk

November 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.